Crude Oil Down Over 4%; Target Earnings Top Views
U.S. stocks mostly fell, led by a 1.32% Dow drop. Target beat estimates and raised guidance; TJX and Bellring rallied, while oil and metals slid.
Follow the latest Iridex Corp. (IRIX) news and market headlines alongside the live IRIX price. Stay informed on what's moving IRIX.
U.S. stocks mostly fell, led by a 1.32% Dow drop. Target beat estimates and raised guidance; TJX and Bellring rallied, while oil and metals slid.
Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose 47.7% to $4.18.
U.S. stocks fell as the Dow slid 300+ points; Nvidia beat Q3 estimates, while energy, commodities and European markets declined.
Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 21.2% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.6 million. As per the press release, Q3 earnings came
Pony AI rose 10.6% after beating Q3 loss estimates but missing sales; Autozi led gainers, while IRIDEX fell 17.6% on results and guidance.
Ardent Health shares slide after hours following $14.50 secondary offering pricing and concurrent share repurchase.
Iridex falls after hours as revenue misses estimates and 2026 outlook is lowered.
Iridex (NASDAQ:IRIX) lowers FY2026 sales outlook from $51.000 million-$53.000 million to $46.000 million-$48.000 million vs $52.521 million estimate.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to IRIX, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.